Skip to main content
OpenTrials
Completed

NCT Number: NCT03466697

Role of Dopamine Transporter in Glucose Control

Healthy subjects will be enrolled in this study. Each subject will be scanned twice with F18-FP-CIT PET which is commercially available. F18-FP-CIT reflects dopamine transporter availability of striatum. Before each PET scan, subject will be injected either glucose or normal saline. Therefore, PET scan will reflect the changes of dopamine transporter availability after the injection of glucose.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pusan National University Hospital

Busan, 49241, South Korea

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy subjects

Exclusion criteria

  • known neurologic disorder
  • known drug addiction
  • known endocrine disorder

Treatment and study plan

Glucose injection/Normal saline injection

Other

Before each PET scan, subject will be injected either glucose or normal saline.

Primary outcomes

  1. Specific binding ratio of dopamine transporter availabilitiy measured from PET scans

    Time frame: less than 1 month

    Specific binding ratio of dopamine transporter availabilitiy measured from PET scans

Sponsors and collaborators

Lead sponsor

Pusan National University Hospital

Other

Registry information

Official study title

Role of Dopamine Transporter in Glucose Loading of Healthy Subjects

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Mar 15, 2018
Registry last updated
Apr 20, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.